Residual inflammatory risk is major driver of CV events and mortality in statin-treated patients

3' education - Mar. 7, 2023 - Prof. Paul Ridker, MD - Boston, MA, USA

Educational information

This video was recorded at the Congress of the American College of Cardiology (ACC) 2023 in New Orleans, LA, USA.

Faculty

Paul M Ridker is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women’s Hospital in Boston, MA, USA.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read our summary of this analysis

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.